Together, these findings suggest, in addition to inducting anti‐apoptosis, IL‐25 promotes cisplatin resistance of lung cancer cells partly by activating NF‐κB signaling pathway to increase the expression of MVP. This evidence concerns the gene IL25 and lung cancer.